• $15.3M
    Market Cap
  • -89.84%
    1-Year Change
  • Diagnostics & Research
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: N/A
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.51
$0.51
$0.51
1-Year Range
$0.51
$3.34
$0.51
Latest Close$0.51
Change
-$0.08 (-16.33%)
Volume200
Market Cap$15.3M
Shares Outstanding30.0M
P/E (TTM)-43.59
Diluted EPS (TTM)-$0.01
Enterprise Value$14.1M

Information as of 02/20/2026

Company Profile

$15.3M
Market Cap
-$352,512.00
Net Income
Sector: Healthcare
Industry: Diagnostics & Research
G3-5-8016 Shui?an Town, Hohhot, China, 010000
86 47 2510 4980

Longduoduo Company Limited, together its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. The company offers range of preventive healthcare services, including disease screening, healthcare treatments, healthcare products, and other services for the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases through third-party healthcare service providers, product suppliers, and sales agents. It also provides meridian-regulating and consciousness restoring iatrotechnics; double blood purification; immunological ozonated autohemotherapy; platelet-rich plasma; relaxation therapy; vegetative nerve regulation; and microwave therapy. The company was founded in 2020 and is headquartered in Hohhot, China.

Key Executives

  • Huibo Xu
  • Hongxiao Zhou
  • Liping Kang

Current Ownership Distribution

  • Insiders15.4M (51.30%)
  • Other14.6M (48.70%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)